The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed.
ClavystBio is a life sciences investor and venture builder. We launch and grow global companies.
Venture capitalclavystbio.comRounds from 2025-03-03 to 2026-10-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Zenflow Zenflow is a medical device company developing innovative therapies for the treatment of benign prostatic hyperplasia (BPH). | Series D Verified against 1 of 16 sources | $52M | 2026-10-05 | [ PART ] |
Callio Therapeutics Dual-payload antibody-drug conjugates (ADCs) for cancer treatment. | Series A |
| $187M |
| 2025-03-03 |
| [ PART ] |